New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity.
about
Class IIa bacteriocins: diversity and new developmentsHigh resolution crystal structure of PedB: a structural basis for the classification of pediocin-like immunity proteinsRecombinant pediocin in Lactococcus lactis: increased production by propeptide fusion and improved potency by co-production with PedCDevelopment of innovative pediocin PA-1 by DNA shuffling among class IIa bacteriocinsLysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Isolation and characterization of pediocin AcH chimeric protein mutants with altered bactericidal activity.Comparative studies of class IIa bacteriocins of lactic acid bacteriaThe pediocin AcH precursor is biologically activeBiochemical and genetic characterization of mundticin KS, an antilisterial peptide produced by Enterococcus mundtii NFRI 7393.Production of active chimeric pediocin AcH in Escherichia coli in the absence of processing and secretion genes from the Pediococcus pap operon.Determination of essential and variable residues in pediocin PA-1 by NNK scanningIsolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system.Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum.Both IIC and IID Components of Mannose Phosphotransferase System Are Involved in the Specific Recognition between Immunity Protein PedB and Bacteriocin-Receptor Complex.The continuing story of class IIa bacteriocinsBacteriocin diversity in Streptococcus and Enterococcus.Insights into structure-activity relationships in the C-terminal region of divercin V41, a class IIa bacteriocin with high-level antilisterial activity.Pediocins: The bacteriocins of Pediococci. Sources, production, properties and applications.Structure and Mode-of-Action of the Two-Peptide (Class-IIb) Bacteriocins.Mutational analysis of mesentericin y105, an anti-Listeria bacteriocin, for determination of impact on bactericidal activity, in vitro secondary structure, and membrane interaction.The bactericidal activity of pediocin PA-1 is specifically inhibited by a 15-mer fragment that spans the bacteriocin from the center toward the C terminus.Delineation of key amino acid side chains and peptide domains for antimicrobial properties of divercin V41, a pediocin-like bacteriocin secreted by Carnobacterium divergens V41.Method for rapid purification of class IIa bacteriocins and comparison of their activities.Engineering increased stability in the antimicrobial peptide pediocin PA-1.Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.Generation of polyclonal antibodies of predetermined specificity against pediocin PA-1A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.Rapid two-step procedure for large-scale purification of pediocin-like bacteriocins and other cationic antimicrobial peptides from complex culture medium.Electrostatic interactions, but not the YGNGV consensus motif, govern the binding of pediocin PA-1 and its fragments to phospholipid vesicles.Differences in susceptibility of Listeria monocytogenes strains to sakacin P, sakacin A, pediocin PA-1, and nisin.Binding of pediocin PA-1 with anionic lipid induces model membrane destabilization.Structure-function analysis of immunity proteins of pediocin-like bacteriocins: C-terminal parts of immunity proteins are involved in specific recognition of cognate bacteriocins.Purification and characterization of a novel class IIa bacteriocin, piscicocin CS526, from surimi-associated Carnobacterium piscicola CS526.Novel expression system for large-scale production and purification of recombinant class IIa bacteriocins and its application to piscicolin 126.The fsr Quorum-Sensing System and Cognate Gelatinase Orchestrate the Expression and Processing of Proprotein EF_1097 into the Mature Antimicrobial Peptide Enterocin O16.Bioengineering: a bacteriocin perspective.Bacteriocins from Lactobacillus plantarum - production, genetic organization and mode of action: produção, organização genética e modo de ação.Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1.Mutational analysis of residues in the helical region of the class IIa bacteriocin pediocin PA-1.Recent Progress in the Chemical Synthesis of Class II and S-Glycosylated Bacteriocins.
P2860
Q27021712-F9488F82-1F29-4CA4-96D4-00AE1152DA3CQ27645033-B0963A93-4F7B-4567-AD88-80D94B338DBEQ28828985-F88B42C5-13AC-49A0-AB40-0660A78F9395Q33289369-E047F864-397C-4898-976C-BD54AE362186Q33664443-0084C6E7-8970-4914-9554-8CB2ED0C3E47Q33708703-8BE27802-4B66-4176-8861-E8A1CF125247Q33719663-4D77A6E9-2C3C-4DAB-804F-6E90C8FF7EFEQ33984988-4F6323BF-E71E-4526-A1AA-5A128C93F8F3Q34057096-3CCDA64D-4EA1-43BF-8C1D-8CE288387AB2Q34070560-9340887D-9595-4B3B-9836-BD1E953676B4Q34431234-1A00E34A-2C64-40E2-A3EB-F062F73EC388Q35023295-C4E53D34-3A7D-47E2-9686-AADA3197E7F0Q35205902-3D6437CB-E691-490C-B7D9-2C270762F283Q36173123-506795E8-69AC-492B-8D3F-ABAFCCF1728DQ36499681-09E54148-6393-48D4-9163-589A8ADAE084Q36651005-EA1BA3D8-FE49-49A2-ACF7-D5311DB4AC5EQ37145102-AE42404B-7EEC-4962-BBAB-032F881C1F9FQ37365458-35EBCFBB-E1DB-4874-A4CF-90ECCB3E2FC8Q37728895-ACC99452-6F45-4717-B1E7-0772AA06FB54Q39303096-6756DA2D-E1CB-4C18-ACB5-F07722F0304EQ39479784-E946F84E-7001-4D39-BA0A-8FB0D7E5C294Q39482411-8228742F-FD29-48E2-B283-83F60AC844C8Q39486003-01654E4C-2B39-49F6-9C5E-0F97304D4B80Q39488238-69546CE2-7F21-48AA-A138-4ACD8FFD817BQ39561070-E56A9860-74DF-40F1-A4EE-62E24EBDD07BQ39563120-BBA34692-B5A4-4269-88FA-39B0E909CF79Q39587506-C6E86FBE-06D9-4D8A-A346-F810145FCE9DQ39649945-606C73A7-54C6-42B3-AFD9-DC9E5E7C481DQ39803652-4354CCE3-7A54-4066-9E2C-A865EF391BA5Q39804825-5EAD251C-F097-4CA4-89D3-B5F49A49127CQ40171924-2EB4F7DE-4D24-4B57-8036-593192177DC0Q40833029-6AA7B9CB-058E-4D43-AA24-F7A7428EB9F7Q40896768-9790B7C4-5356-4371-830B-523CEDCF0DEAQ40937527-34BAD714-0C45-4E42-881C-8CE55E1F2D3CQ41315891-552EF620-CEFE-46C3-9243-ECCF90D01A38Q41476222-0EFAC18E-251E-46AB-8B47-AA6AEDF4749AQ41835145-B12C17CF-A320-4A08-BA44-FD48835B5171Q42122101-DA65435C-418E-472B-A9D0-57918E1826DFQ42157038-D8FF90D0-1053-45F2-BAB9-0E3EDF99C993Q54959662-9C6AF9B1-7F9C-4CA6-BC2C-95D95CBA3331
P2860
New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
New biologically active hybrid ...... t for determining specificity.
@en
New biologically active hybrid ...... t for determining specificity.
@nl
type
label
New biologically active hybrid ...... t for determining specificity.
@en
New biologically active hybrid ...... t for determining specificity.
@nl
prefLabel
New biologically active hybrid ...... t for determining specificity.
@en
New biologically active hybrid ...... t for determining specificity.
@nl
P2093
P2860
P1476
New biologically active hybrid ...... nt for determining specificity
@en
P2093
P2860
P304
P407
P577
1996-09-01T00:00:00Z